TRCT
CVAC

Tower Research Capital (TRC)’s CureVac CVAC Stock Holding History

Tower Research Capital (TRC)’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,045
Closed -$16.4K – 5217
2025
Q3 		$16.4K Buy
3,045
+1,890
+164% +$10.2K ﹤0.01% 3477
2025
Q2 		$6.27K Sell
1,155
-11,587
-91% -$46K ﹤0.01% 4116
2025
Q1 		$35.5K Buy
12,742
+6,963
+120% +$24.2K ﹤0.01% 2483
2024
Q4 		$19.7K Buy
5,779
+9
+0.2% +$26 ﹤0.01% 3195
2024
Q3 		$17K Sell
5,770
-245
-4% -$807 ﹤0.01% 3340
2024
Q2 		$20.5K Buy
6,015
+2,436
+68% +$7.97K ﹤0.01% 3754
2024
Q1 		$10.8K Buy
3,579
+111
+3% +$390 ﹤0.01% 3638
2023
Q4 		$14.6K Sell
3,468
-2,122
-38% -$11.5K ﹤0.01% 3877
2023
Q3 		$38.2K Sell
5,590
-3,346
-37% -$29.6K ﹤0.01% 2795
2023
Q2 		$93.1K Buy
8,936
+7,402
+483% +$66.2K ﹤0.01% 2074
2023
Q1 		$11K Sell
1,534
-4,674
-75% -$40.7K ﹤0.01% 4198
2022
Q4 		$37K Buy
6,208
+4,589
+283% +$33.9K ﹤0.01% 2558
2022
Q3 		$13K Sell
1,619
-2,211
-58% -$25.8K ﹤0.01% 4261
2022
Q2 		$52K Buy
3,830
+2,714
+243% +$44.9K ﹤0.01% 2836
2022
Q1 		$21K Sell
1,116
-2,415
-68% -$48.2K ﹤0.01% 3479
2021
Q4 		$121K Buy
3,531
+3,253
+1,170% +$131K ﹤0.01% 2107
2021
Q3 		$15K Sell
278
-7,448
-96% -$449K ﹤0.01% 3966
2021
Q2 		$567K Buy
+7,726
New +$772K 0.01% 1082

Other funds holding CVAC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Tower Research Capital (TRC)'s CVAC Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of CureVac (CVAC) in Q4 2025, closing a stake of 3,045 shares — an estimated $16.4K sold.

Tower Research Capital (TRC) first reported a position in CVAC in Q2 2021 and held it in 18 quarters. The position peaked at $567K in Q2 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Tower Research Capital (TRC) reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 3,045 CureVac shares in Q4 2025, an estimated $16.4K.
  • Tower Research Capital (TRC) first reported a position in CureVac in Q2 2021 and held it in 18 quarters.
  • Tower Research Capital (TRC)'s CureVac position peaked at $567K in Q2 2021.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.